Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart valve design aims to outperform current standards

NCT ID NCT07194265

Summary

This study will test a new artificial heart valve called DurAVR against currently available valves for people with severe aortic stenosis. About 1,650 participants will be randomly assigned to receive either the new valve or an existing one, then followed for up to 10 years. The goal is to see if the new valve is safer and more effective at controlling this serious heart condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE AORTIC STENOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.